Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C

Abstract

In CHC, SF is a useful marker for assessing disease duration and progression before starting treatment and for predicting therapeutic response while on therapy. SF rise during antiviral therapy is largely independent of hemolysis and likely indicates activation of macrophages in response to antivirals.